VivArt-X closes an extension round with Borski Fund

VivArt-X has successfully closed an extension funding
round with the impact-oriented Borski Fund onboard, alongside previous
investors Brabant Startup Fund, TUe Participations B.V., BOM and a group of informal investors.

Borski is renowned for its commitment to supporting female entrepreneurs and addressing the gender financing gap. By participating in this extension funding round, Borski once again demonstrates its determination to provide equal opportunities to female entrepreneurs, as well as addressing important issues around health equity and tackling the women’s health gap.

“We are incredibly grateful for Borski’s support and for sharing the same vision,” said Dan Jing Wu, CEO of VivArt-X. “This investment enables us to accelerate our mission and improve women’s healthcare through innovation and technology.”

According to research by McKinsey closing the women’s health gap could add 1.7% to global GDP, representing a $1 trillion opportunity
in economic potential. Meanwhile, Sie Ventures FemTech market research reports that only 4% of healthcare R&D is targeted at women’s health issues. By getting more women in investment decision making positions Borski aims to ensure that these gaps for women are reduced across the board.

This investment not only propels VivArt-X’s research and development endeavours but also amplifies its capacity to drive innovation and technological advancements in women’s healthcare. 

Investing in women’s health companies has also proven to provide positive returns on investment for investors, as reportedly for every $1 invested, approximately $3 is reflected in economic growth. According to the European Investment Bank, female-founded companies deliver twice as much revenue per dollar investment than their male counterparts, while only receiving 1% of VC funding in 2021.

As Simone Brummelhuis from Borski says “This investment demonstrates the triple effect of Borski fund: mobilizing capital of among others female investors, closing the financing gap for female founders, and tackling the women’s health gap. Our fund is unique in its unwavering commitment to enabling women across all fronts and creating new opportunities.”

With this extended investment round, Borski continues its commitment to closing the financing gap for female entrepreneurs and catalysing transformative developments in women’s health. This news marks an important milestone for both Borski and VivArt-X, promising a positive impact on the health and well-being of women worldwide.

About BorskiFund
Borski Fund is a diversity tech VC fund headquartered in the Netherlands.  The fund strategically invests in climate tech and sustainable solutions, health care companies and futures society propositions. With 17 investments having been made to date, Borski Fund primarily targets Western European-based companies with international aspirations, offering support to entrepreneurs through their extensive network and entrepreneurial experience. The €40 million fund, founded by Simone Brummelhuis and Laura Rooseboom, is dedicated to promoting diversity and gender equality.